Evidence map›Paper›PMID 25587799›Full record

ArticleJAMA psychiatry2015

Spontaneous Gamma Activity in Schizophrenia.

Yoji Hirano, Naoya Oribe, Shigenobu Kanba, Toshiaki Onitsuka, Paul G Nestor, Kevin M Spencer

Abstract read
In one paragraph

Article in JAMA psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  6. Trial
  7. Temporal stability of functional network configurations and its relationship to cognition and psychopathology in early psychoses.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  13. Abnormal spontaneous activity and rest-task shift in schizophrenia.Psychiatry and clinical neurosciences · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Biological psychiatry global open science · 2025
    Article
  18. Review
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoji HiranoNeural Dynamics Laboratory, Research Service, Veterans Affairs Boston Healthcare System, Boston, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts3Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyus.
Naoya OribeNeural Dynamics Laboratory, Research Service, Veterans Affairs Boston Healthcare System, Boston, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts3Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyus.
Shigenobu KanbaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Toshiaki OnitsukaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Paul G NestorNeural Dynamics Laboratory, Research Service, Veterans Affairs Boston Healthcare System, Boston, Massachusetts4Department of Psychology, University of Massachusetts, Boston.
Kevin M SpencerNeural Dynamics Laboratory, Research Service, Veterans Affairs Boston Healthcare System, Boston, Massachusetts2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Funding

Electrophysiological Endophenotypes of Schizophrenia in Mouse and ManR01MH093450 · NIMH · GALENEA CORPORATION · PI LEVIN, MARGARET, SPENCER, KEVIN M · 2012 to 2016
$2.9M
Neural Dynamics in SchizophreniaR01MH080187 · NIMH · HARVARD MEDICAL SCHOOL · PI SPENCER, KEVIN M · 2008 to 2012
$1.4M
Neurophysiological Studies of Visual Perception in SchizophreniaI01CX000154 · VA · VA BOSTON HEALTH CARE SYSTEM · PI SPENCER, KEVIN M · 2009 to 2015
–
CSRD VA I01 CX000154NIMH NIH HHS R01 MH080187NIMH NIH HHS R01MH080187NIMH NIH HHS R01 MH093450NIMH NIH HHS R01MH093450
6 · The paper itself

Abstract

importanceA major goal of translational neuroscience is to identify neural circuit abnormalities in neuropsychiatric disorders that can be studied in animal models to facilitate the development of new treatments. Oscillations in the gamma band (30-100 Hz) of the electroencephalogram have received considerable interest as the basic mechanisms underlying these oscillations are understood, and gamma abnormalities have been found in schizophrenia (SZ). Animal models of SZ based on hypofunction of the N-methyl-d-aspartate receptor (NMDAR) demonstrate increased spontaneous broadband gamma power, but this phenomenon has not been identified clearly in patients with SZ.

objectiveTo examine spontaneous gamma power and its relationship to evoked gamma oscillations in the auditory cortex of patients with SZ. DESIGN, SETTING, AND

participantsWe performed a cross-sectional study including 24 patients with chronic SZ and 24 matched healthy control participants at the Veterans Affairs Boston Healthcare System from January 1, 2009, through December 31, 2012. Electroencephalograms were obtained during auditory steady-state stimulation at multiple frequencies (20, 30, and 40 Hz) and during a resting state in 18 participants in each group. MAIN OUTCOMES AND MEASURES: Electroencephalographic activity in the auditory cortex was estimated using dipole source localization. Auditory steady-state response (ASSR) measures included the phase-locking factor and evoked power. Spontaneous gamma power was measured as induced (non-phase-locked) gamma power in the ASSR data and as total gamma power in the resting-state data.

resultsThe ASSR phase-locking factor was reduced significantly in patients with SZ compared with controls for the 40-Hz stimulation (mean [SD], 0.075 [0.028] vs 0.113 [0.065]; F1,46 = 6.79 [P = .012]) but not the 20- or the 30-Hz stimulation (0.042 [0.038] vs 0.043 [0.034]; F1,46 = 0.006 [P = .938] and 0.084 [0.040] vs 0.098 [0.050]; F1,46 = 1.605 [P = .212], respectively), repeating previous findings. The mean [SD] broadband-induced (30-100 Hz) gamma power was increased in patients with SZ compared with controls during steady-state stimulation (6.579 [3.783] vs 3.984 [1.843]; F1,46 = 9.128 [P = .004]; d = 0.87) but not during rest (0.006 [0.003] vs 0.005 [0.002]; F1,34 = 1.067 [P = .309]; d = 0.35). Induced gamma power in the left hemisphere of the patients with SZ during the 40-Hz stimulation was positively correlated with auditory hallucination symptoms (tangential, ρ = 0.587 [P = .031]; radial, ρ = 0.593 [P = .024]) and negatively correlated with the ASSR phase-locking factor (baseline: ρ = -0.572 [P = .024]; ASSR: ρ = -0.568 [P = .032]). CONCLUSIONS AND RELEVANCE: Spontaneous gamma activity is increased during auditory steady-state stimulation in SZ, reflecting a disruption in the normal balance of excitation and inhibition. This phenomenon interacts with evoked oscillations, possibly contributing to the gamma ASSR deficit found in SZ. The similarity of increased spontaneous gamma power in SZ to the findings of increased spontaneous gamma power in animal models of NMDAR hypofunction suggests that spontaneous gamma power could serve as a biomarker for the integrity of NMDARs on parvalbumin-expressing inhibitory interneurons in humans and in animal models of neuropsychiatric disorders.

Indexed as

Acoustic StimulationAuditory CortexCase-Control StudiesCross-Sectional StudiesEvoked Potentials, AuditoryGamma RhythmHallucinationsHumansRestSchizophrenia

Identifiers

PMID25587799
PMCPMC4768724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.